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Abstract
Plasmodium parasites express a potent inhibitor of cysteine proteases (ICP) throughout their life cycle. To analyze the role of
ICP in different life cycle stages, we generated a stage-specific knockout of the Plasmodium berghei ICP (PbICP). Excision of
the pbicb gene occurred in infective sporozoites and resulted in impaired sporozoite invasion of hepatocytes, despite
residual PbICP protein being detectable in sporozoites. The vast majority of these parasites invading a cultured hepatocyte
cell line did not develop to mature liver stages, but the few that successfully developed hepatic merozoites were able to
initiate a blood stage infection in mice. These blood stage parasites, now completely lacking PbICP, exhibited an attenuated
phenotype but were able to infect mosquitoes and develop to the oocyst stage. However, PbICP-negative sporozoites
liberated from oocysts exhibited defective motility and invaded mosquito salivary glands in low numbers. They were also
unable to invade hepatocytes, confirming that control of cysteine protease activity is of critical importance for sporozoites.
Importantly, transfection of PbICP-knockout parasites with a pbicp-gfp construct fully reversed these defects. Taken
together, in P. berghei this inhibitor of the ICP family is essential for sporozoite motility but also appears to play a role during
parasite development in hepatocytes and erythrocytes.
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Introduction
Every year over 200 million people suffer from malaria infection
worldwide, with an estimated 655,000 deaths annually (WHO,
2011). The causative agent of malaria is the unicellular parasite
Plasmodium that belongs to the phylum Apicomplexa. Much effort
has been made to develop drugs against this parasite, however
multi-drug-resistant Plasmodium strains are frequently identified
in field isolates [1–3] and new strategies to combat malaria are
therefore urgently needed.
Cysteine proteases play a pivotal role in the life cycle of
Plasmodium parasites and, thus, might be good targets for anti-
malarial strategies. Plasmodium cysteine proteases are involved in
a variety of biological processes, such as hemoglobin degradation,
protein trafficking, rupture of membranes, host cell invasion, and
egress from host erythrocytes and host hepatocytes [4–13].
Cysteine proteases are also believed to mediate the unusual form
of programmed host cell death that occurs at the end of liver stage
development and which clearly differs from classical apoptosis
[13,14]. Furthermore, cysteine proteases are essential for parasite
development in the mosquito vector [15]. Processing of the major
surface protein CSP (circumsporozoite protein), which is critical
for hepatocyte invasion, is mediated by a still unidentified parasite
cysteine protease [16].
In higher eukaryotes, cysteine proteases are controlled by
endogenous inhibitors such as cystatins and a2-macroglobulin. In
protozoa, no cystatin homologs have been identified, but a family
of cysteine protease inhibitors (ICPs) has recently been described.
The first identified ICP was chagasin from Trypanosoma cruzi
[17]. Subsequently, ICPs have been found in Trypanosoma brucei
[18], Leishmania [19], Entamoeba histolytica [20], and all
Plasmodium species analyzed thus far including human, rodent
and avian Plasmodium species [21,22]. Related proteins have been
described in Pseudomonas aeruginosa but are absent from
multicellular eukaryotes [23]. Recently, the structure of the ICPs
from Leishmania mexicana, T. cruzi, and Plasmodium berghei
were described as immunoglobulin-like [24,25]. ICPs inhibit
parasite proteases, in the case of T. cruzi [26] and T. brucei [27],
and both parasite proteases and host cell proteases in the case of
Leishmania [19].
Plasmodium ICPs belong to the MEROPS I42 family of
inhibitors. They are tight-binding, reversible inhibitors of cathep-
sin-L-type cysteine proteases but do not block the activity of
cathepsin-B- and C-like proteases [28]. Whereas the Plasmodium
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falciparum ICP (PfICP or falstatin) is a weak caspase inhibitor, the
P. berghei ICP (PbICP) is not capable to inhibit caspases at all
[25,29]. All known Plasmodium ICPs consist of a C-terminal
chagasin-like domain and a long N-terminal domain of unknown
function. PfICP has been analyzed extensively during blood stage
development. It is expressed by mature schizonts, merozoites, and
young ring stages but not by trophozoites [22]. During merozoite
egress, PfICP is released upon rupture of the infected erythrocyte.
Pre-incubation with anti-PfICP antiserum leads to decreased
infectivity of blood stage merozoites, suggesting that PfICP has a
role in limiting unwanted proteolysis during erythrocyte invasion
[22].
In pre-erythrocytic stages, ICPs have been investigated in
rodent and avian Plasmodium species. The ICP of Plasmodium
gallinaceum is expressed and secreted by salivary gland sporozoites
[21]. By contrast, PbICP is constitutively expressed and proteo-
lytically processed throughout the life cycle of the parasite. While
the N-terminal part of the protein is rapidly degraded after
processing, the chagasin-like C-terminal part is sufficient for
inhibition of cysteine proteases [25,29]. In sporozoites, PbICP co-
localizes with the thrombospondin related anonymous protein
(TRAP) in micronemes and is secreted by salivary gland
sporozoites and young liver stage trophozoites [29]. Our previous
results suggested that PbICP promotes hepatocyte invasion by
sporozoites since pre-incubation with anti-PbICP serum resulted
in a significant impairment of sporozoite invasion [29]. During
liver stage development, PbICP is predominantly detected in the
parasite cytosol and the parasitophorous vacuole (PV) [29]. Upon
parasitophorous vacuole membrane (PVM) breakdown, PbICP is
released into the host cell cytosol. PbICP has the capacity to
interfere with the host cell apoptosis machinery by blocking host
cell cysteine proteases involved in cell death execution [29].
In contrast to PbICP expression in sporozoites, the ICP of
Plasmodium yoelii (PyICP) was mainly detected in rhoptries and
only partially co-localized with TRAP in micronemes [30]. PyICP
was not detected in protein trails left behind by gliding parasites or
following induction of microneme secretion, nor did pre-treatment
of salivary gland sporozoites with an antiserum to PyICP inhibit
hepatocyte invasion. However, these contradictory results could not
be clarified since all attempts to delete PyICP were unsuccessful
[30]. Interestingly, in the same study, down-regulation of PyICP did
not affect blood stage development, but PyICP knockdown
parasites could not be recovered from infected mosquitoes [30].
This result led to the hypothesis that Plasmodium ICPs might
only be essential for development of the parasite in the
mosquito. In a recent study describing the successful knockout
of the icp gene in P. berghei this result was confirmed [31].
Here, PbICP knockout sporozoites were not able to migrate to
salivary glands and to infect hepatocytes. In contrast to this
study, we have employed a stage-specific knock out approach
[32]. This technique allowed us to analyze the function of
PbICP during the entire life cycle of Plasmodium. Although the
main phenotype associated with PbICP loss was detected in pre-
erythrocytic stages, PbICP-negative parasites also exhibited a
clear attenuated phenotype in the blood stage, confirming an
important role of cysteine protease regulation by PbICP in all
major life cycle stages. Complementation of PbICP-deficient
parasite clones with a pbicp-gfp construct reversed all knockout
defects, confirming that the observed effects are indeed due to
the lack of the inhibitor.
Results
1. Generating pbicp knock out and add-back parasite
strains
To analyze the function of PbICP during the entire life cycle of
the parasite we generated three different parasites clones: a
conditional knockout clone (PbICPcond) to analyze the role of
PbICP in liver stage development, a complete knockout clone
(PbICPKO) to investigate whether PbICP is essential for any
particular parasite stage and a pbicp complementation on the
PbICPKO background (PbICPcomp) to confirm that the observed
effects are indeed PbICP-derived.
To obtain PbICPcond parasites we employed the UIS4/Flp
conditional gene deletion approach that has been described
previously [33,34]. In this approach, the Saccharomyces cerevisiae
site-specific recombinase Flp is expressed under the sporozoite-
specific uis4 promoter. We first introduced FRT sites into the 39
regulatory sequence (UTR) of the pbicp locus by double crossover
homologous recombination [33,35]. However, even though
excision of the FRTed 39UTR occurred with great efficiency in
salivary gland sporozoites, it was not sufficient to completely
suppress expression of the pbicp gene. Therefore, using an
alternative strategy, one FRT site was introduced between the
sequence coding for the C-terminal inhibitor domain and the N-
terminal domain of the protein (Figure S1A, pPbICP/FRT).
Following integration by double crossover homologous recombi-
nation, Flp-mediated excision of the sequence between both FRT
sites (pbicp 39coding region and 39UTR) was expected to block
expression of the functional inhibitor.
The linearized pPbICP/FRT was transfected into the non-
fluorescent NK65 P. berghei receiver clone, UIS4/Flp(2) [33].
The expected double crossover recombination event in the
parasite population was confirmed by PCR using different sets
of primers (Figure S1B). Subcloning by limiting dilution was
performed and a clone (PbICPcond) that had successfully integrated
the pPbICP/FRT construct into the correct locus was isolated
(Figure S1C).
For the complete knockout, the PbICPcond clone was passaged
through mosquitoes and hepatocytes. Single detached cells were
injected into mice for direct cloning [36] and the clone obtained
was named PbICPKO. Similar to previous work [31], these PbICP-
deficient parasites could establish a blood stage infection.
Finally, to complement the deletion of the pbicp-c locus, we
transfected PbICPKO parasites with a plasmid that allows
expression of pbicp-gfp under the control of the constitutive
Author Summary
Coordinated protease activity is essential to parasite
survival. Throughout its life cycle, the Plasmodium parasite
expresses a potent cysteine protease inhibitor that has the
potential to inhibit parasite as well as host cell cysteine
proteases. We have generated a stage-specific knockout of
this inhibitor and were able to analyze its function in all life
cycle stages. Interestingly, although constitutively ex-
pressed, the inhibitor primarily appears to play an
important role in sporozoite gliding, liver stage develop-
ment and egress from hepatocytes whereas blood stage
parasites lacking the inhibitor exhibited only mild atten-
uation. Parasite sexual stage development was not
affected and development continued normally within the
mosquito. However, sporozoites lacking the inhibitor show
a strong phenotype; they are completely blocked in
motility and thus cannot transmigrate or invade cells.
Complementation of knockout parasites by exogenous
expression of the inhibitor completely restored parasite
virulence.
Essential Protease Inhibitor for Plasmodium Parasite Development
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promoter pbeef1aa [29] (Figure S2A). Selection of transgenic add-
back parasites (PbICPcomp) was facilitated by the fact that, in
PbICPKO parasites, the hDHFR resistance cassette was removed
during the excision event (Figure S1A). Integration of pbicp-gfp
(and of gfp as a control) by single crossover into the ssurna locus of
PbICPKO parasites was confirmed by PCR analysis using gDNA
extracted from transfected PbICPKO and control UIS4/Flp(2)
blood stage parasites (Figure S2B). To confirm that the GFP fusion
does not block the inhibitor function of PbICP, protease assays
were performed with recombinant fusion proteins expressed in E.
coli bacteria: 200 nM of either MBP-PbICP or MBP-PbICP-GFP
were equally able to inhibit the cysteine protease papain (Figure
S2C).
2. PbICP is not essential for parasite blood stage
development but its deficiency results in a marked
attenuation
Genotyping of blood stage parasites from different clonal
parasite populations confirmed the presence of the pbicp locus
in PbICPcond parasites and its excision in PbICPKO and add-
back parasites (PbICPcomp) (Figure 1A, upper panel). As
expected, pbicp DNA was detected in PbICPcond and
PbICPcomp parasites. In PbICPcond parasites, the pbicp gene
was only slightly modified by the addition of FRT sites and
thus allowed amplification of a pbicp fragment by PCR
(Figure 1A, lower panel). In PbICPcomp parasites part of the
pbicp locus was deleted but the integration of the pbicp-gfp
cassette into the ssurna locus also allowed amplification of a
diagnostic pbicp fragment by PCR.
To confirm PbICP expression in PbICPcond and PbICPcomp
parasites, protein extracts were prepared from the different blood
stage parasite strains and Western blot analysis using antiserum
directed against PbICP-C was performed (Figure 1B). The PbICP-
C antiserum detected bands of 55 kDa and 23 kDa in control
parasites (P. berghei strain expressing the Flp recombinase, UIS4/
Flp(2)) and PbICPcond parasites, corresponding to the full-length
and processed PbICP, respectively, as described earlier [29].
Although the modified PbICP in PbICPcond parasites, harboring
the FRT site in the open reading frame, is expected to be slightly
larger (2 kDa), no size differences could be detected by Western
blot analysis, most likely because the gel was unable to resolve this
small difference (Figure 1B, lane 1 and 2). No PbICP protein was
detected in PbICPKO parasites (Figure 1B, lane 3), but expression
of full-length PbICP-GFP (81 kDa) as well as the processed form,
PbICP-GFP (49 kDa), was detected in cell extracts of PbICPcomp
parasites (Figure 1B, lane 4).
Although PbICP is not essential for blood stage development,
we wanted to determine whether knockout of the inhibitor has an
effect on parasite development at this stage. Blood from mice
infected with PbICPKO, PbICPcomp, or control parasites was
transferred to naı¨ve mice by i.p. injection. In comparison to
control parasites, the increase in parasitemia of PbICP-deficient
parasites was clearly delayed (Figure 1C, left graph), indicating a
significant level of attenuation of these parasites. By contrast,
PbICPcomp parasites and control parasites did not differ in the
establishment of parasitemia (Figure 1C, right graph) confirming
that exogenous expression of the PbICP-GFP fusion protein fully
restored virulence to blood stage parasites. The differences in
parasitemia with the different parasite strains was statistically
evaluated at day 3 when all mice were still alive (Figure S2D). As
expected, parasitemia in mice infected with PbICPKO parasites
was significantly lower than in mice infected with control or add-
back parasites (PbICPcomp).
3. PbICP is not essential for sporozoite development in
oocysts but abolishes sporozoite motility and invasion of
salivary glands
The PbICPcond clone was used to infect mosquitoes and excision
of pbicp-c was followed by PCR analysis (Figure S1C). It is
important to note that in parasites with freshly excised genes,
translation of the already produced mRNA is still ongoing and
thus protein is expected to be expressed for several hours. This was
very important for us as it has been shown that the traditional
knockout of the pbicp gene completely blocked sporozoite invasion
of hepatocytes [31] and one of the main objectives of the present
study was to analyze the role of PbICP during liver stage
development. Although excision is very efficient it is never
complete [33]. We therefore expected that in a very small fraction
of parasites the gene would not be excised and that these parasites
would show a normal phenotype.
Before we analyzed hepatocyte invasion and liver stage
development, we first investigated the development of PbICPKO
and PbICPcomp parasites in mosquitoes and compared them to
control parasites. Oocysts were counted and sporozoites were
collected from midguts, hemocoel, and salivary glands at different
times and counted. At day 10 post-infection, the number of oocysts
(Figure S3A) and the development of sporozoites in the oocysts
(Figure S3B) appeared to be similar in all three parasite clones. At
day 18 post-infection, the number of midgut sporozoites as well as
the release of sporozoites into the hemocoel was still not
significantly different (Figure 2A). However, by this stage only
very few PbICPKO sporozoites reached the salivary glands, similar
to a previous report for PbICPKO parasites obtained by a
traditional knockout strategy [31]. It should be noted that at later
stages (20–26 days post-infection), more parasites had accumulated
in the salivary glands and allowed a restricted set of experiments
(see below). Importantly, exogenous constitutive expression of
PbICP-GFP in PbICPcomp parasites completely restored salivary
gland infectivity confirming that the observed phenotype was
indeed due to the loss of PbICP (Figure 2A). Since we confirmed
excision in PbICPcond parasites occurred during development in
the salivary glands (Figure S1C), we next investigated PbICP
expression in salivary gland sporozoites by IFA using a specific
anti-PbICP-C antiserum. PbICPcond sporozoites expressed levels
of PbICP comparable to control sporozoites (Figure 2B) although
excision of the gene was very efficient (Figure S1C). Since
translation of already produced mRNA is still ongoing, PbICP
protein was expected to be expressed for several hours. In
addition, we reasoned that already expressed PbICP is stored in
micronemes during sporozoite development and is available for
successful invasion of hepatocytes. In this experiment PbICPKO
sporozoites served as a negative control (Figure 2B) and confirmed
the specificity of the anti-PbICP-C antiserum. In PbICPcomp
sporozoites, PbICP-GFP expression was detected by the anti-
PbICP-C antiserum as well as an anti-GFP antibody (Figure 2B).
The predominant phenotype of PbICPKO sporozoites is
impaired gliding motility (Figure S3C). Importantly, PbICP-GFP
expression restored gliding motility of sporozoites as evidenced by
CSP positive circles around the parasite (Figure 2B, bottom panel).
Interestingly, these circles were also positive for PbICP-GFP,
confirming secretion of the inhibitor as suggested earlier [21,29].
To understand the molecular basis of impaired gliding motility
in PbICPKO sporozoites, we investigated proteins known to be
involved in this process. CSP processing is important for switching
from the sporozoite migratory state to the invasion state [37].
Processing of CSP is mediated by a cysteine protease and given
that both ICP and CSP proteins are secreted by sporozoites
[29,37], we hypothesized that PbICP could be one of the
Essential Protease Inhibitor for Plasmodium Parasite Development
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Figure 1. PbICP is not essential for parasite blood stage development. (A) Assessment of SSR at the pbicp locus in pbicp-transgenic parasites
(PbICPcond, PbICPKO, and PbICPcomp) by PCR of genomic DNA using primers P1 and P3 (see Figure S1). PbICPKO erythrocytic stages were generated by
subcloning of PbICPcond parasites via single merosome injection into mice. PbICPcomp erythrocytic stages were generated by transfection of PbICPKO
parasites with the pL0017-pbicp-gfp plasmid [29] as a complementation (add-back) for pbicp. The sizes of the DNA fragments amplified from pbicp
excised (SSR+) or non-excised (SSR2) loci are shown. As a control, primers specific for pbicp were used (bottom panel). (B) Western blot analysis of
extracts from blood stage parasites. In vitro cultured parasites were collected at the schizont stage. Analysis included the following strains: PbICPcontrol
Essential Protease Inhibitor for Plasmodium Parasite Development
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regulatory factors in CSP processing. We reasoned that premature
CSP processing would prevent parasite migration. Indeed when
CSP was analyzed in midgut and salivary gland lysates of
PbICPKO sporozoites by Western blot, it was extensively processed
compared to control or PbICPcomp parasites (Figure 2C, upper
panel).
However, since PbICPKO parasites are strongly impaired in
gliding, the phenotype is clearly different from mutant parasites
that only express the processed form of CSP on their surface.
These CSP mutant sporozoites are able to glide and invade cells
but cannot complete their migration from the inoculation site of
the skin [37]. We therefore concluded that loss of PbICP must also
affect key proteins important for gliding motility, such as TRAP
[38]. TRAP is a transmembrane protein that connects the
parasite’s motor complex to the substrate. Normal gliding requires
proteolytic cleavage of TRAP to remove its bound extracellular
adhesion domains [39]. In a previous study, we localized TRAP
and PbICP to parasite micronemes [29], therefore we investigated
TRAP processing in the absence of the inhibitor (in PbICPKO
parasites). Protein extracts of PbICPKO salivary gland sporozoites
demonstrated a major processed form of TRAP (approximately
75 kDa), instead of the 95 kDa form found in supernatant of
control parasites (Figure 2C, lower panel). This result argues for
alternative TRAP processing in PbICPKO parasites. To exclude
the possibility that the observed processing is a non-specific event
due to death of the parasites, we performed metabolic labeling.
Salivary gland PbICPKO parasites incorporated equivalent
amounts of radio-labeled amino acids as control parasites,
confirming that PbICPKO parasites are metabolically active and
viable (Figure S3D).
4. PbICP is essential for sporozoite transmigration and
invasion of hepatocytes
In a previous study, incubation of salivary gland sporozoites
with anti-PbICP antiserum neutralized PbICP and led to
significantly reduced levels of HepG2 infection but had no effect
on the ability of sporozoites to traverse cells [29]. Now we found
that PbICP-deficient sporozoites exhibited severely impaired
gliding motility (Figure S3C) and, thus, it was not surprising that
PbICPKO parasites were not able to transmigrate through host
cells (Figure S3E). We therefore reasoned that loss of PbICP-C has
more severe effects on sporozoite biology than those elicited by
neutralization of secreted protein(s) by the anti-PbICP antiserum.
Following transmigration, sporozoites invade hepatocytes and
reside within a PV. In invasion assays, we counted infected HepG2
cells at 5 and 30 hours after incubation (hpi) with control,
PbICPcond, PbICPKO, or PbICPcomp sporozoites (Figure 3A and
S4A). Overall, significantly fewer PbICPcond parasites than control
parasites successfully infected cells, although all PbICPcond
sporozoites and early-invaded parasites (5 hpi) still expressed
PbICP. The amount of PbICP protein was likely reduced owing to
the gene deletion. PbICP might be stored to a certain extent in
some compartments involved in invasion (i.e., micronemes) and
allow invasion of at least some parasites. However, analysis of
protein concentration is beyond the resolution of IFA. IFA is an
extremely powerful qualitative method, but it is not suitable for
determining small differences in protein concentration because
photo-bleaching cannot be precisely controlled. Still, as we
observed PbICP-negative parasites already at 30 hpi, excision
obviously results in a marked drop of PbICP levels.
An essential role of PbICP in invasion was revealed when
PbICPKO parasites were investigated. Remarkably, not a single
PbICPKO sporozoite was able to invade a HepG2 cell, whereas
PbICPcomp parasites exhibited an even improved invasion rate
compared to the control strain (Figure 3A). This result is consistent
with a previous study showing that overexpression of a PbICP-
GFP fusion protein had a positive effect on invasion of HepG2
cells compared to wild-type parasites [29].
Since recombinantly expressed PbICP maintains the capacity to
inhibit cysteine proteases [29] we reasoned that externally added
recombinant PbICP might restore the invasion phenotype in
PbICPKO parasites by blocking unregulated processing of TRAP.
However, we did not observe any effect of added inhibitor on
invasion of HepG2 cells by PbICPKO parasites (Figure S4C) and
concluded that unregulated processing of TRAP might occur
within the parasite rather than following secretion. Obviously,
externally added recombinant PbICP did not have access to
intracellular compartments and, thus, could not prevent process-
ing. This assumption is supported by the fact that PbICP and
TRAP co-localized in micronemes [29]. It will now be highly
interesting, although very challenging, due to the small number of
salivary gland sporozoites, to investigate TRAP and CSP
processing in PbICPKO parasites in detail.
Together, all phenotypes observed in PbICPKO sporozoites can
be explained by the lack of gliding motility. Salivary gland
invasion, as well as transmigration and finally invasion of
hepatocytes, all depend, at least in part, on gliding motility.
Successful metabolic labeling of PbICPKO parasites confirmed that
the parasites are still viable. Importantly, the add-back parasite
strain expressing PbICP-GFP reversed the strong knockout
phenotypes completely, confirming that the observed defects are
indeed due to the lack of the inhibitor.
5. PbICP is important for liver stage development
Liver stage development is characterized by an extensive growth
phase. To investigate intrahepatic growth of PbICP-C-deficient
parasites, the size of fixed PbICPcond parasites in infected HepG2
cells was analyzed at 30 hpi and 60 hpi and compared to control
exo-erythrocytic forms (EEFs). PbICP-negative PbICPcond para-
sites were significantly smaller compared to controls at 30 hpi and
the difference became even more pronounced 60 hpi (Figure 3B).
To determine whether PbICP-negative parasites were develop-
mentally delayed, we examined the expression and localization of
different parasite marker proteins that have distinct subcellular
localizations and expression profiles throughout EEF develop-
ment. HepG2 cells were infected with salivary gland sporozoites of
(UIS4/Flp(2)), PbICPcond, PbICPKO, and PbICPcomp parasites. PbICP-C was detected using a specific mouse anti-PbICP-C antiserum [29]. Rat anti-MSP1
was used as a control. Molecular masses are indicated in kDa. The expected mass of full-length PbICP is 55 kDa in PbICPcontrol and 57 kDa in PbICPcond
parasites and 23 kDa after processing (PbICP-C). PbICP-GFP has an expected molecular mass of 81 kDa and 49 kDa after processing (PbICP-C-GFP). (*:
non-specific protein bands, probably Ig subunits remaining in the blood culture detected by the secondary HRP-labeled anti-mouse antibody). (C)
Blood stage development of PbICPcontrol (UIS4/Flp(2)), PbICPKO and PbICPcomp parasites. Mice were infected by i.p. injection of 100 ml blood from
infected mice, adjusted to a parasitemia of 5% with PBS. The onset and development of a blood stage infection was determined by observation of
blood smears. The two graphs represent two separate sets of experiments. In the left graph, parasitemia of PbICPcontrol and PbICPKO parasites were
compared and, in the right graph, parasitemia of PbICPcontrol and PbICPcomp parasites were compared. For statistical evaluation of the difference in
parasitemia at day 3 see Figure S2D.
doi:10.1371/journal.ppat.1004336.g001
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control, PbICPcond or PbICPcomp parasites and fixed at different
times after infection (Figure 4 and 5A). At the trophozoite/early
schizont stage, infected cells were examined by IFA using an
antibody that stains the PVM-marker protein Exp1 (Figure 4). For
later stages, an antibody detecting the GPI-anchored parasite
membrane (PM) protein MSP1 was used (Figure 5A, Figure S5A),
which is expressed from the late schizont stage onwards and is
essential for the formation of hepatic merozoites [33]. Anti-PbICP-
C antiserum was used to distinguish PbICP-negative and -positive
parasites in the PbICPcond population. PbICPcomp parasites were
not stained with anti-MSP1 antibodies, because four-color staining
was limited by the detection of expression of PbICP-GFP fusion
protein. However, PbICPcomp parasites develop to infectious
merozoites, indicating that they express MSP1 normally.
IFAs of parasites fixed at 30 hpi (trophozoite/schizont stage)
showed that PbICP-negative PbICPcond parasites appear to be
retarded in development compared to control parasites (Figure 4).
At this stage, control and PbICPcomp schizonts had already started
schizogony characterized by multiple nuclei, whereas most PbICP-
negative parasites were still at the trophozoite stage with a single
nucleus (Figure 4). A PbICP deficiency at this stage did not affect
maintenance of the PVM.
At 48 hpi (late schizont stage), we frequently observed that
PbICP-negative parasites were smaller in size, but the PVM
showed normal dimensions and thus the lumen of the PV was
much larger than that of control parasites, where the PV is hardly
seen (Figure 4). From 55 hpi onwards, PbICP-negative parasites
exhibited an abnormal nuclear distribution and did not develop
into the characteristic cytomere stage (Figure S5A). At 60 hpi
parasites were counted and distinguished by IFA in infected cells
with PbICP positive and PbICP negative parasites (Figure S5B)
and their size was measured (Figure 3B). In contrast to 30 hpi
(Figure 3A), at 60 hpi most parasites were found to be PbICP
negative. The number of PbICPcond parasites was significantly
reduced in comparison with control parasites but was similar to
the numbers of invaded PbICPcond parasites at 30 hpi (Figure 3A)
suggesting that PbICPcond parasites that are able to invade, persist
but are obviously smaller (Figure 3B) and developmentally
retarded (Figure S5A).
6. PbICP is important for hepatic merozoite egress
Our next aim was to analyze the final steps of liver stage
development of PbICP-negative parasites. Merozoites egress from
infected hepatocytes in packets called merosomes, which is a
tightly regulated process involving proteases [13,40]. We hypoth-
esized that PbICP is an important regulatory element in this
process. To address the consequences of PbICP depletion on
merosome formation, HepG2 cells were infected with control,
PbICPcond, PbICPKO, or PbICPcomp parasites. At 48 hpi, the
number of infected cells was counted and this value was
normalized to 100% of the successfully developing parasite
population. Since PbICPKO parasites did not infect HepG2 cells
at all, they were not included in further analysis. Detached cells
and merosomes were harvested at 65 hpi but only detached cells
(containing a Hoechst 33342-positive host cell nucleus) were
counted to determine the number of infected cells completing
development (Figure 5B). Including budded merosomes (without a
host cell nucleus) in the counting would have artificially increased
the developmental success rate. As shown in Figure 5B, at 65 hpi,
only 6.9% of PbICPcond parasites had completed development, in
contrast to 36.2% of control and 31.7% of PbICPcomp parasites.
To exclude the possibility that PbICPcond parasites are only
delayed in development, we monitored detachment between 65
and 70 hpi and no additional detached cells were detected for
PbICPcond parasites (Figure S5C). The significant reduction in the
ability of the PbICPcond population to form detached cells
confirmed our original hypothesis that PbICP is an important
regulator of parasite cysteine proteases involved in egress.
To analyze merozoite formation and detached cell morphology
in more detail, IFA of control, PbICPcond and PbICPcomp parasites
was performed. In most control parasites, in vitro merozoite
formation is completed at approximately 60 hpi (Figure S5A). The
resultant merozoites are homogenous in size and shape and are
surrounded by a MSP1-positive membrane. The PVM starts to
disintegrate as shown by fragmented Exp1 staining and merozoites
are released into the host cell cytoplasm. PbICP-negative
PbICPcond parasites, by contrast, exhibited abnormal MSP1 and
Exp1 staining around clusters of parasites. In contrast to control
parasites, only a few merozoite-like structures could be detected in
PbICP-negative parasites and these were surrounded by MSP1-
positive membranes (Figure S5A). The majority of these parasites
formed large vacuole-like structures surrounded by MSP1-positive
membranes. These data clearly show that PbICP expression is
crucial for parasite development and merozoite formation.
Nonetheless, a small proportion of PbICP-negative parasites were
able to complete development and induce host cell detachment
(Figure 5A, middle panel). These few parasites may have
maintained PbICP levels longer than others and were thus able
to continue development. PbICP-negative parasites also contained
merozoites with an abnormal morphology and some were not
even surrounded by MSP1-positive membranes (Figure 5B,
middle panel; S5A). Interestingly, the few normally developed
MSP1-positive merozoites in detached cells, which derived from
PbICPcond parasite-infected cells, were infective by the single
detached cell injection method (which was, in fact, the method
used to generate PbICPKO parasites, as described earlier).
In contrast to PbICPcond parasites, PbICPcomp parasites grew
normally in HepG2 cells and were able to complete liver stage
Figure 2. PbICP is essential for mosquito stage development and regulates CSP and TRAP processing by midgut and salivary gland
sporozoites. (A) Quantification of sporozoite numbers in the mosquito midgut, hemolymph, and salivary glands. Mosquitoes infected with
PbICPcontrol (control), PbICPKO (KO), or PbICPcomp (comp) parasites were dissected at day 18 after blood feeding, and the number of sporozoites in the
mosquito midgut (MG), hemolymph (HL), or salivary glands (SG) was determined. Ten mosquitoes were dissected per time point, pooled, and the
average number of sporozoites per mosquito was determined; therefore, no standard deviations are shown. The experiment was repeated with two
independent groups of infected mosquitoes. One representative experiment is shown. (B) IFA of a PbICPcontrol (first panel), PbICPcond (second panel),
PbICPKO (third panel), or PbICPcomp (fourth panel) sporozoite isolated from infected mosquito salivary glands. Sporozoites were fixed and stained with
mouse anti-GFP (green), rat anti-PbICP-C (red), and rabbit anti-CSP (cyan). Secondary antibodies: anti-mouse Alexa 488, anti-rat Alexa594 and anti-
rabbit Alexa488 or Alexa647; DNA was stained with DAPI (blue). Scale bars, 5 mm. (C) Upper panel: Western blot analysis of extracts from infected
mosquito midguts (Left panel, collected 11 days after infection) or salivary glands (Right panel, collected 19 days after infection) infected with
PbICPcontrol, PbICPKO, or PbICPcomp sporozoites using an antibody recognizing unprocessed (unproc.) and processed (proc.) CSP. Lower panel:
Western blot analysis of total lysate or supernatant (generated by centrifugation of incubated sporozoites prior to lysis) from infected salivary glands
(collected 20 days after infection). Mosquitoes were infected with PbICPcontrol or PbICPKO sporozoites and antibody recognizing unprocessed
(unproc.), processed (proc.), or alternatively processed (alt. proc.) TRAP was used. Molecular masses are indicated in kDa.
doi:10.1371/journal.ppat.1004336.g002
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Figure 3. PbICP is important for effective invasion of and development within hepatocytes. (A) Quantification of infected HepG2 cells
incubated with either 16104 PbICPcontrol (UIS4/Flp(2)), PbICPcond, PbICPKO, or PbICPcomp parasites at 30 hpi is shown. Suitable amounts of PbICPKO
sporozoites, could be harvested from salivary glands at day 24–26 after blood feeding only. For consistency, also mosquitoes infected with the other
parasite strains were also used at day 24–26 after blood feeding. Differentiation of PbICP-C-positive (striped bars) or PbICP-C-negative (black bars)
EEFs was quantified by IFA. Results are the means6 standard deviation (S.D.) from three independent experiments. The relative infection rate (rel. inf.
rate) of PbICPcontrol, PbICPcond, PbICPKO, and PbICPcomp parasites is shown below the histogram. Differences between PbICPcontrol and pbicp-
transgenic parasites (PbICPcond, PbICPKO, and PbICPcomp) were compared using Student’s t test (* = P,0.05, **** = P,0.0001). (B) Parasite size during
exo-erythrocytic development (at 30 and 60 hpi) in PbICPcond parasites compared with PbICPcontrol parasites, as determined using density slicing
(OpenLab). Results are the means 6 S.D. from three independent measurements. Differences between PbICPcontrol and PbICPcond parasites were
compared using Student’s t test (* = P,0.05; **** = P,0.0001).
doi:10.1371/journal.ppat.1004336.g003
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development (Figure 5A, lower panel and 5B), confirming that i)
the observed phenotype in PbICPcond parasites is indeed due to the
knockout of pbicp and ii) PbICP-GFP is capable of complementing
the knock out phenotype in exo-erythrocytic stages.
7. PbICP is essential for exo-erythrocytic development in
vivo
To investigate the in vivo infectivity of the different parasite
strains generated in this study, we infected mice with equal
numbers of salivary gland sporozoites and monitored parasitemia.
In vivo infectivity of PbICPcond sporozoites was dramatically
reduced. Compared to control mice where 9 of 10 sporozoite
injections resulted in a blood stage infection, only 1 mouse out of
10 developed a blood infection when PbICPcond sporozoites were
injected (Table 1). Strikingly, no blood infection could be detected
in mice after injection of PbICPKO sporozoites, while the
PbICPcomp parasites elicited infection rates similar to control
parasites (Table 1).
Taken together, parasites lacking PbICP are greatly impaired in
invasion of salivary glands and are incapable of infecting
hepatocytes, confirming the predicted role of PbICP in sporozoite
invasion processes.
Discussion
This study provides evidence that PbICP expression is essential
for both P. berghei sporozoite invasion of salivary glands in
mosquitoes and of hepatocytes in the mammalian host, as well as
for successful liver stage development. Mutants lacking PbICP
exhibited attenuated blood stage development but ookinete
formation and migration, as well as oocyst and sporozoite
formation, were all unaffected in the deletion mutant. Importantly,
the severe defects observed were completely reversed by expres-
sion of a PbICP-GFP fusion protein. The fact that the
complementation completely reverts the strong knockout pheno-
types clearly argues against a dominant-negative effect of the non-
excised and thus probably transcribed PbICP-N domain. ICPs
have been identified in all Plasmodium species analyzed thus far
including human, rodent and avian species [21,22] and they are
rather conserved, suggesting that they have important functions in
all Plasmodium species. However, this does not exclude the
possibility that ICPs of different Plasmodium species have
additional or even differing functions. In contrast to P. berghei
(this study and [31]), generating ICP knockout parasites has not
been possible for the closely related P. yoelii and also PyICP
appears not to be secreted by P. yoelii sporozoites [30]. Attempts
to delete the P. falciparum ICP (PfICP or falstatin) failed and it
appears to be more important for blood stage development [22]
than PbICP (this study and [31]). Bearing this in mind, the
suggested function of PbICP in this study cannot necessarily be
generalized as the function of ICPs in other Plasmodium species.
Precise control of cysteine protease activity is essential
for motility and invasion in P. berghei pre-erythrocytic
stages
The data obtained in this study indicate that impaired invasion
of salivary glands by PbICPKO sporozoites is due to a lack of
gliding motility. Gliding motility is a substrate-dependent form of
active motion that is powered by a subpellicular actomyosin
system. The actomyosin complex is linked to the sporozoite surface
by members of the TRAP family, which are secreted from
specialized secretory organelles called micronemes [38,41]. TRAP
is a type I transmembrane protein exhibiting an extracellular
adhesive domain and a cytoplasmic domain that binds to F-actin
and hence connects to myosin A [42,43]. The forward motion of
sporozoites results from the posterior translocation of the
substrate-TRAP-motor complex assembly. Drug treatments,
mutations of the motility machinery, or deletion of TRAP all
result in motility defects [38,42]. Furthermore, non-motile
sporozoites are incapable of invading host cells, which directly
links gliding motility to host cell invasion. For fast and effective
gliding motility, a delicate balance between adhesion and
detachment must be achieved [44,45]. Adhesins may be proteo-
lytically processed either intracellularly (en route to or within the
micronemes) or extracellularly after their release onto the surface
[46]. Extracellular processing is required to break interactions
between the parasite surface and host cell and also to control
exposure of adhesive domains in parasite-host cell interactions. In
a recent study TRAP was shown to be processed and, thus,
removed from the sporozoite surface by a rhomboid serine
protease. If canonical rhomboid activity is prevented, TRAP
accumulates on the surface and motility is significantly reduced,
linking serine proteases to the process of host cell invasion [39].
However, in parasites with a mutated rhomboid cleavage site,
cleavage of TRAP, albeit inefficient, is mediated by another
unknown protease. This processing occurs at an alternative
juxtamembrane cleavage site and the processed TRAP is smaller
in size [39]. Interestingly, the size of the cleaved form of TRAP in
PbICPKO sporozoites was much smaller than in control parasite
lysates and comparable in size to TRAP processed at the
alternative site.
Pre-incubation of PbICPKO sporozoites with recombinant
PbICP did not reverse the immotile phenotype of sporozoites;
therefore, we hypothesize that the unregulated TRAP site is
processed intracellularly. In T. gondii, the endogenous cathepsin-
L-like protease TgCatL is localized in a vacuolar compartment
and functions as a protein maturase within the endo/exocytic
system. TgCatL mediates proteolytic maturation of propeptides
targeted to micronemes [47]. If such a compartment also exists in
P. berghei, PbICP could control the activity of cathepsin-L-like
proteases during maturation of micronemal proteins. In fact,
PbICP and TRAP localize to the same compartments, namely,
micronemes [29] and, when PbICP is absent, a putative cysteine
protease might become active prematurely. Taken together, our
results imply that not only serine proteases but also cysteine
proteases are important for motility and invasion and their precise
regulation is essential for gliding motility.
The decrease in both mosquito salivary gland and vertebrate
liver infectivity of PbICPKO sporozoites can be explained entirely
by ICP’s role in gliding motility. However, it cannot be excluded
that part of these phenotypes is due to the premature processing of
CSP observed in PbICPKO sporozoites. Previous studies have
shown that CSP is processed by a parasite cysteine protease,
resulting in removal of the N-terminal part of the protein which
leads to exposure of its C-terminal cell-adhesion domain [37]. As
sporozoites migrate from the mosquito midgut to the mammalian
liver, the N-terminus masks the cell adhesion domain that appears
to maintain the sporozoite in a migratory mode. Upon contact
with hepatocytes, CSP is cleaved, the adhesive domain is exposed
and there is an associated switch from a migratory to an invasive
state. Mutant sporozoites, which constitutively express only the
cleaved form of CSP on their surface, do not efficiently invade
mosquito salivary glands because they non-specifically bind to
other organs in the mosquito hemocoel and when injected
intradermally into the mammalian host, they cannot exit the
inoculation site in the skin. However, when placed directly onto
hepatocytes, they invade normally. So although dysregulation of
CSP cleavage could interfere with sporozoite infectivity of
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Figure 4. Morphological differences in PbICPcond EEF development. IFA of HepG2 cells infected with either PbICPcontrol (control), PbICPcond
(cond), or PbICPcomp (comp) parasites, fixed 30 hpi (trophozoite/schizont stage) or 48 hpi (late schizont stage) after infection. Cells were stained with
mouse anti-P. berghei or mouse anti-GFP (green), rat anti-PbICP-C (red) and chicken anti-ExpI (cyan). Secondary antibodies were: anti-mouse
Alexa488, anti-rat Alexa594, and anti-chicken Cy5. DNA was stained with DAPI (blue). Scale bars: 5 mm.
doi:10.1371/journal.ppat.1004336.g004
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Figure 5. PbICP is Important for EEF Maturation. (A) IFA of infected, detached cells 65 hpi (mature EEFs) of either PbICPcontrol (first panel),
PbICPcond (second panel), or PbICPcomp (third panel) parasites. Cells were stained with mouse anti-MSP1 or mouse anti-GFP (green), rat anti-PbICP-C
(red), and chicken anti-ExpI (cyan). Secondary antibodies were: anti-mouse Alexa488, anti-rat Alexa594, or anti-chicken Cy5. DNA was stained with
DAPI (blue), Scale bars: 10 mm. (B) Quantification of infected, detached cells 65 hpi (mature EEFs) of the different parasite strains in relation to infected
cells 48 hpi. HepG2 cells were infected with either PbICPcontrol (control), PbICPcond (cond), or PbICPcomp (comp) sporozoites and infected cells were
quantified 48 hpi (values normalized to 100%). At 65 hpi, supernatant was collected and stained with Hoechst 33342. The number of infected,
detached cells was quantified and the ratio between infected cells at 48 hpi and detached cells at 65 hpi was calculated. Results are the means6 S.D.
from three independent measurements. Differences between PbICPcontrol and pbicp-transgenic parasites (PbICPcond, PbICPcomp) were compared using
Student’s t test (**** = P,0.0001; ns, not significant). PbICPKO parasites were excluded from this experiment as no invasion could be achieved. n.a.:
not applicable.
doi:10.1371/journal.ppat.1004336.g005
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mosquito salivary glands and infectivity in the mammalian host
after inoculation by mosquito bite, our finding of severe
attenuation of hepatocyte infectivity of PbICPKO sporozoites, i.e.
in vitro and in vivo, points to another primary cause, namely
TRAP processing and its impact on gliding motility.
PbICPcond as well as PbICPKO sporozoites showed a severe
defect in hepatocyte invasion. While PbICPcond sporozoites had a
significantly reduced ability to infect hepatocytes, PbICPKO
sporozoites were completely blocked in this regard. These results
strongly support the hypothesis that PbICP is critical for
hepatocyte invasion. All PbICPcond parasites that were able to
infect hepatocytes were initially positive for PbICP. The reasons
why their invasion ability and intracellular development differs
quite substantially from PbICPKO parasites are manifold. First,
excision is not coordinated among salivary gland sporozoites as it
depends on uis4 promoter activity that is activated in late
sporozoite stages and is still active in the liver stage. Excision might
therefore occur at any of these stages. Secondly, even upon
excision of the gene, the mRNA is still present and can be
transcribed. The amount of pbicp mRNA may vary within a
parasite population. Another fact to consider is that PbICP is a
rather stable protein and protein turnover may vary within a
parasite population. Lastly, a few parasites stayed PbICP-positive
until the end of liver stage development and we assume that in
these parasites the pbicp gene was not excised.
Given these data, PbICPcond salivary gland sporozoites are likely
to exhibit variations in their loss of PbICP over time. We
hypothesize that the amount of PbICP in sporozoite is the
determining factor for a successful invasion event. If PbICP levels
are too low, or the protein is absent, cysteine protease activity is
enhanced and premature processing of key invasion molecules
occurs, resulting in defective invasion.
The essential role of PbICP in sporozoite invasion of both
mosquito salivary glands and hepatocytes provides an eminently
suitable target for pre-erythrocytic intervention strategies.
PbICP deficiency results in severe defects during liver
stage development
In comparison to control parasites, PbICPcond liver stage
parasites were clearly delayed in development and growth
(Figure 4, 5, and S5). Morphological analysis revealed defects in
nuclear replication, PV maintenance, PM invagination, and
merozoite formation. Cysteine proteases are important for parasite
development throughout the liver stage [13,16] and the data
presented here confirm this. Although the exact function of PbICP
during liver stage development remains to be determined, some
features of PbICP-deficient parasites are very interesting. Very few
PbICP-deficient parasites developed to the cytomere stage and
beyond. The fact that some parasites still succeeded suggests that
they either had sufficient PbICP protein that was beyond the limit
of detection by IFA, or that PbICP was dispensable for their
development. If the latter is true, how can it be that the inhibitor is
non-essential for some parasites? A possible explanation would be
that PbICP is an emergency protease inhibitor during liver stage
development, which inhibits accidentally-released and activated
cysteine proteases. Because accidental release does not occur in
every case, some parasites can complete development even without
PbICP.
This study also confirmed our earlier observation of PbICP
being necessary for merozoite egress from hepatocytes (Figure 5).
Cysteine proteases are involved in breakdown of the PVM in late
liver stage development. When infected cells were treated with the
cysteine protease inhibitor E64 in vitro [13], PVM rupture did not
occur and only very few infected cells were able to detach. Upon
PVM disintegration, merozoites are released into the host cell
cytosol, a process that is closely associated with induction of an
unusual type of host cell death. Host cysteine proteases such as
caspases, calpain, and cathepsins, which are often key enzymes in
programmed cell death, are not activated and other classical signs
of programmed cell death, such as DNA fragmentation and
disintegration of the host cell plasma membrane, are absent [13].
Since breakdown of the PVM also correlates with release of PbICP
into the host cell cytosol, the inhibitor may modulate activation of
apoptosis by inhibiting cysteine proteases [29].
A recent study hypothesized that PbICP, in addition to its
inability to inhibit calpain-1, and cathepsin-B and -C type cysteine
proteases, cannot inhibit SERA proteases [25], which play a role
in PVM breakdown. Although protease activity of SERAs has not
been confirmed, it is widely accepted that they are involved in
parasite egress [5]. Of the nine SERA proteases identified in P.
falciparum, PfSERA5 and PfSERA6 have been refractory to gene
deletion. Processing of PfSERA5 is essential for egress of blood
stage merozoites from the erythrocyte. The first known step in this
cascade is DPAP3-mediated subtilisin 1 (SUB1) processing, which
is then released into the PV lumen, where it processes PfSERA5
[5,7,48–50]. PfSERA5 then triggers downstream processing of
cellular substrates and has been associated with 28 interaction
partners in a protein-association network study [51]. In P. berghei,
the homolog of PfSERA6, PbSERA3, is highly expressed and
processed in late liver stages (presumably by PbSUB1), where it
localizes to the PVM/PV. Upon breakdown of the PVM, it is
released into the host cell cytoplasm [52]. Presumably cysteine
proteases of the parasite that are not inhibited by PbICP are
involved in PVM breakdown. Parasite cysteine proteases of the
cathepsin-B or -C type are therefore likely candidates to mediate
PVM breakdown. SERA proteases might be involved as well, but
the molecular mechanism remains to be elucidated. Upon PVM
breakdown, Plasmodium ICPs prevent an immediate and, thus,
Table 1. PbICP is essential for parasite development in vivo.
parasite line #mice positive/#mice injected prepatent period (days)
PbICPcontrol 9/10 5.761.22
PbICPcond 1/10 7
PbICPKO 0/10 -
PbICPcomp 4/5 5.860.5
In vivo infectivity of pbicp-parasites was determined by parasite prepatency. Mice (5–10 per treatment group) were infected with 56103 PbICPcontrol, PbICPcond, PbICPKO,
or PbICPcomp salivary gland sporozoites by intravenous (i.v.) inoculation. The onset of a blood stage infection (prepatency) was determined by observation of blood
smears up to 20 days post-infection. Non-infected mice were not considered in the prepatency calculations.
doi:10.1371/journal.ppat.1004336.t001
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premature host cell death by inhibiting host cell cathepsin-L-like
proteases. Parasite proteases initiate an ordered and slow host cell
death that cannot be inhibited by ICPs.
Irrespective of the underlying mechanism, late liver stage
development and egress processes were greatly impaired in
PbICP-negative PbICPcond parasites and only very few infected
host cells were able to detach, confirming a role for PbICP at this
stage. The precise role of PbICP during host cell death processes at
the end of liver stage development is subject of current research.
PbICP-C deletion attenuates blood stage parasites
The few PbICP-negative merosomes successfully isolated in
vitro were injected into naı¨ve mice and were capable of
establishing a blood stage infection confirming a recent study in
which the entire pbicp gene was deleted [31]. In contrast to our
data, no effect on blood stage development was observed in the
previous study. This was surprising because attempts to knockout
the icp gene in the closely related parasite P. yoelii [30] and the
human parasite P. falciparum [22] have failed, suggesting an
important role for this inhibitor during the blood stage. Indeed, we
did not succeed to delete this gene in P. berghei using straight
knockout approaches suggesting an important role for this
inhibitor during the blood stage as well. Since gene deletion in
the previous study occurred in the blood stage [31], selective
pressure to compensate for the loss of the inhibitor was high and
the obtained knockout clones may have carried modifications in
addition to the pbicp knockout. In our study, we obtained blood
stage parasites by injecting mice with hepatocyte-derived mero-
zoites and, thus, the parasites did not have the chance to adapt to
the loss of PbICP by compensatory mutations or epigenetic
modifications. Furthermore, we showed a complete reversion of
the pbicp knockout phenotype by add-back transfection of
PbICPKO parasites, strongly suggesting that the observed effects
are solely due to the loss of PbICP function. In the previous study
[31], this complementation experiment was not performed, which
leaves the possibility that compensatory modifications occurred in
the obtained clones. However, all other observed effects match
very well in both studies, confirming the important role of PbICP
in gliding motility, ordered CSP processing, and invasion. Analysis
of the PbICP deficiency in liver stage development was not
possible in the previous study since hepatocyte invasion was
completely blocked in pbicp knockout sporozoites [31].
The question of why the constitutively expressed ICPs are not
equally important for different life cycle stages remains. During
blood stage development, cysteine proteases are mainly active in
the food vacuole, where premature activation of cysteine proteases
might have less deleterious effects. In the food vacuole, the major
role of falcipains and other proteases is to degrade hemoglobin to
provide nutrients for the parasite. By contrast, liver schizonts do
not form food vacuoles and falcipains might localize to other
compartments of the parasite, where deleterious effects might be
more likely.
Another reason why ICPs are more crucial for some stages than
others might be due to differences in gliding distances and the
length of time required to reach the relevant host cell. Most
apicomplexan invasive stages are released in close proximity to
their future target host cell and do not need to move large
distances. For example, when erythrocytic-stage merozoites are
released within a blood vessel, parasites do not need to glide to
infect a new RBC. By contrast, sporozoites developing in oocysts
in the mosquito midgut wall are far from their ultimate target, the
mammalian liver. After passive circulation in the hemocoel of the
insect, they actively enter the mosquito salivary glands, from where
they are inoculated into the mammalian dermis, actively exit the
dermis to enter the blood circulation and, upon being carried by
the blood stream to the liver, actively penetrate the sinusoidal
barrier of the liver to reach the hepatocytes [53]. Thus, sporozoites
need to remain viable and infective for an extended period of time,
which, in turn, requires a prolonged and precise regulation of
protease activity. Since merozoite invasion of RBCs is a fast
process, tightly regulated protease activity might be less important.
Differences in invasion strategies among sporozoites of different
Plasmodium species may also be possible [37,53]. If these strategies
involve different proteases, the severity of phenotypes observed in
pbicp deficient parasites at different life cycle stages might be
affected.
Interestingly, ICPs from other protists have also been shown to
function during invasion processes. Crypotastatin, an ICP of
Cryptosporidium parvum, may play a role in invasion of host cells
[54], the overexpression of chagasin in T. cruzi reduces the
infection rate in vitro and in vivo, and a chagasin null mutant had
a lower differentiation rate due to changes in activity of parasite
cell surface cysteine proteases [26,27,55]. However, T. brucei
chagasin null mutants reached higher parasitemia levels in mice
[27]. In T. cruzi, chagasin promotes modulation of cysteine
protease zymogens in the Golgi apparatus and its deletion causes
higher zymogen conversion, disruption of intracellular traffic, and
abnormalities in the secretory pathway, which, surprisingly, leads
to increased virulence in vivo [18,56].
The ICP of L. mexicana is secreted by the parasite and even
though a lack of ICP had no impact on infectivity in vitro, ICP
overexpressors, as well as knockout parasites, showed a reduced
virulence and infectivity in vivo [19]. These observations suggested
that LmICP regulates proteases of the host rather than those of the
parasite. The in vivo roles of the E. histolytica ICP are
neutralization of endogenous parasite proteases to regulate self-
proteolysis, as well as inactivation of host proteases during parasite
invasion [20]. In T. cruzi, cruzipain is released by trypomastigotes
and was shown to promote host cell invasion by processing a
trypomastigote molecule associated with parasite-shed membranes
[26].
Overall, these studies confirm the general importance of tight
regulation of cysteine proteases involved in invasion, growth and
egress by endogenously expressed protease inhibitors. Our work
provides evidence that ICPs are the molecular regulators of
cysteine protease activity during several life cycle stages of
Plasmodium parasites. These results may allow new and innovative
approaches to control Plasmodium invasion and intracellular
development.
Materials and Methods
Experimental animals
This study was carried out in strict accordance with the
guidelines of the German Tierschutzgesetz (TierSchG; Animal
Rights Laws). Mice were obtained from Charles River Laborato-
ries. The protocol was approved by the Department of Veterinary
Affairs of the Hamburg state authorities (Permit Number: FI 28/
06). Blood feeding was performed under ketavet/rompun anes-
thesia, and all efforts were made to minimize suffering.
Parasites and mosquitoes
All parasites are derivatives of Plasmodium berghei strain NK65.
Anopheles stephensi mosquitoes were reared using standard
procedures [57]. Mosquitoes were fed on infected mice 3–5 days
after parasite injection and kept at 21uC with 70% humidity. For
in vitro experiments, sporozoites were isolated from infected
salivary glands 18–25 days after the infectious blood meal.
Essential Protease Inhibitor for Plasmodium Parasite Development
PLOS Pathogens | www.plospathogens.org 13 August 2014 | Volume 10 | Issue 8 | e1004336
Construction of plasmids
The backbone of the targeting plasmid (Phdhfr/FRT-Flp) has
been described previously [32].
The plasmid pPbICP/FRT contains the following elements,
listed with the numbers of the relevant primer pairs in parentheses.
In pPbICP/FRT, the first 0.85 kb (1) (PbICP-N) of the PbICP
coding sequence (PlasmoDB: PBANKA_081300) is immediately
followed by 16 nucleotides (tcgttttcgtttaact), a first FRT site, the last
0.7 kb (2) (PbICP-C) of the PbICP coding sequence, the hdhfr
39regulatory sequence (3) (0.45 kb), the hdhfr cassette, the second
FRT site, the plasmid backbone and 0.76 kb (4) of the PbICP
39regulatory sequence. The coding and regulatory sequences of
pbicp and hdhfr were cloned from gDNA of P. berghei NK65 wild-
type blood stages or Phdhfr/FRT-Flp plasmid using Phusion Taq
High-Fidelity DNA polymerase (Finnzyme) and the following
primer pairs: (1)fw, 59 -ATGCATGCCGTGTTTAATATATG-
fCTCCATCCTAGCC- 39, and (1)rv, 59 -ATATGCGGCCG-
CAGTTAAACGAAAACGATATATCTTCGCTATTATCAGA-
AAAATTACTTGCTG- 39; (2)fw, 59-ATGATATCGAAGA-
TAATCAAAAATACCCAACTAC- 39, and (2)rv, 59-ATGA-
TATCTTATTGGACAGTCACGTATATAATTTTAGTG- 39;
(3)fw, 59-ATATGGGCCCCGTTTTTCTTACTTATATATT-
TATACCAAT- 39, and (3)rv, 59-ATATGGGCCCATTGAAG-
GAAAAAACATCATTTG- 39; (4)fw, 59-ATATAAGCTTGTA-
TATATGCGTATATATAATATATGCAATAATAATTTTT-
TTTTATGCC- 39, and (4)rv, 59-ATGCATGCGAAATTGTG-
GAAAGAATGAAAAAGGGGTG- 39.
A transgenic conditional pbicp-c knock out (KO) parasite line
that was generated, later subcloned and named PbICPcond.
The Plasmodium berghei expression plasmid pL0017 (pL0017-
GFP), obtained from Chris Janse through the Malaria Research
and Reference Reagent Resource Center (www.mr4.org), was
used to generate the PbICPcontrol-GFP parasite line. The pL0017-
PbICP-GFP plasmid was generated previously [29] and was used
as an add-back construct in this study. The transgenic PbICPKO-
add-back parasite line that was generated is referred to as
PbICPcomp.
GFP and the fusion protein PbICP-GFP are expressed via the
pbeef1aa promoter. The pL0017 plasmid contains target sequenc-
es for integration into the c- or d-ssu-rRNA locus of the genome
and the tgdhfr/ts selectable marker cassette, which allows selection
of transfected parasites using pyrimethamine.
P. berghei transfection
P. berghei erythrocytic stages of the receiver strain PbNK65
UIS4/Flp(2) [33] (PbICPcontrol) and the PbICPKO strain (de-
scribed below) were transfected by electroporation using Amaxa
technology, as described previously [58]. When the parasitemia in
parental and transfer mice was higher than 5%, infected blood was
collected by cardiac puncture and P. berghei genomic DNA was
extracted and analyzed.
The uncloned transgenic PbICPcond parent parasite line was
cloned by limiting dilution of blood stage parasites. Integration of
the pPbICP/FRT constructs (Figure S1B) into the genome of the
UIS4/Flp(2) strain was analyzed by diagnostic PCR using the
following primers:
P1(fw): 59- ATGATATCGAAGATAATCAAAAATACC-
CAACTAC.
P2(rv): 59- TTAAACGAAAACGAAAGAATGAAAAAGGG-
GTGTACTTGTTATATC -39.
P3(rv): 59- CATCGACCCTTTCTCTGTATGAACATCT-
TCTAC -39.
P4(fw): 59- CCCAGCTTAATTCTTTTCGAG.
pbicp: (fw) 59- GAAGATAACGACATATACTCTTTTGA-
TATC -39; (rv) 59- TTATTGGACAGTCACGTATATAAT -39.
PbICPcond always refers to subcloned parasites if not mentioned
specifically that it still is uncloned.
Genomic integration of the pL0017-PbICP-GFP construct into
the PbICPKO strain and of pL0017-GFP into the UIS4/Flp(2)
strain (Figure S2B) was analyzed by diagnostic PCR using the
following primers:
P1(fw): 59- ATACTGTATAACAGGTAAGCTGTTATT-
GTG -39.
P2(fw): 59- GTGTAGTAACATCAGTTATTGTGTG -39.
P3(rv): 59- TTTCCCAGTCACGACGTTG -39.
P4(rv): 59- CTTAGTGTTTTGTATTAATGTCGATTTG -
39.
Cloning of PbICPcond parasites via merosome injection
The transgenic PbICPcond parasite line was cloned by injection
of a single infected detached hepatocyte or merosome into mice, as
previously described [36]. Briefly, HepG2 cells were infected with
PbICPcond sporozoites and the resulting detached infected
hepatocytes were collected 65 hours later. Individual detached
cells were isolated and injected intravenously into 6- to 8-week-old
female NMRI mice. The cloned parasites from the resulting blood
stage infections were collected and used for further analysis.
Correct excision of pbicp-c was analyzed by PCR (Figure 1A) and
expression of PbICP-C was analyzed by Western blot (Figure 1B).
The subcloned transgenic PbICPcond parasite line generated is
referred to as PbICPKO.
Culture of HepG2 cells
HepG2 cells were cultured in Minimum Essential Medium
(MEM) with Earle’s salts (Gibco) supplemented with 10% heat-
inactivated FCS (Sigma), 1% penicillin/streptomycin, and 1% L-
glutamine (all from PAA Laboratories, Austria). Cells were
cultured at 37uC and 5% CO2 and maintained by twice-weekly
passage using Accutase (PAA Laboratories, Austria).
Infection of HepG2 cells with P. berghei sporozoites
For infection, HepG2 cells were seeded in 24-well plates (Nunc).
Salivary glands of female A. stephensi mosquitoes infected with
UIS4/Flp(2) (control or PbICPcontrol), PbICPcontrol-GFP, PbICP-
cond, PbICPKO or PbICPcomp parasites, were isolated, collected in
PBS and stored on ice. After disruption of the salivary glands using
a pestle, sporozoites were quantified using a hemocytometer.
HepG2 cells were incubated with the desired number of
sporozoites in 200 ml MEM per well for 1 h at 37uC in 5%
CO2. The medium was then changed to standard HepG2 growth
medium (see above) supplemented with 2.5 mg/ml Amphotericin
B (PAA).
Immunofluorescence analysis (IFA)
Sporozoite IFA. Sporozoites were isolated from salivary
glands of A. stephensi mosquitoes and incubated on glass coverslips
without HepG2 cells in MEM (PAA) containing 3% heat-
inactivated FCS, 1% L-glutamine, 1% penicillin, and 1%
streptomycin at 37uC in 5% CO2. After 2 h, medium was
carefully removed and sporozoites were fixed with 4% parafor-
maldehyde (PFA) in PBS (20 min, room temperature), permeabi-
lized with ice-cold methanol (10 min), incubated with primary
antisera (rat anti-PbICP-C (generated in the Heussler laboratory at
the BNITM in Hamburg), rabbit anti-CSP and mouse anti-GFP),
and, subsequently, with fluorescently labeled secondary antibodies
(anti-rat Alexa594 and anti-rabbit or anti-mouse Alexa488 and
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anti-rabbit Alexa647-labeled antibodies, Molecular Probes). DNA
was visualized by staining with 10 mg/ml DAPI (Sigma). Labeled
cells were analyzed by confocal laser scanning microscopy using an
Olympus FV1000 (and Olympus Fluoview 1.7b Software).
IFA of infected HepG2 cells. HepG2 cells were infected as
described above. After the indicated time periods, cells were
fixed with 4% PFA in PBS (20 min, room temperature),
permeabilized with ice-cold methanol (10 min at room temper-
ature or over night at 220uC), and incubated with primary
antibodies (chicken anti-ExpI, mouse anti-P. berghei (raised
against mixed blood stage parasites), mouse anti-MSP1, rat anti-
PbICP-C (generated in the Heussler laboratory at the BNITM
in Hamburg), mouse anti-GFP (Roche) and rabbit anti-UIS4)),
and, subsequently, with fluorescently labeled secondary anti-
bodies (Cy5-labeled antibody (Dianova) and Alexa594/488-
labeled antibodies (Molecular Probes)). DNA was visualized by
staining with 10 mg/ml DAPI (Sigma). Stained cells were
analyzed as described above.
IFA of infected, detached HepG2 cells. HepG2 cells were
infected as described above. At 68 h post-infection (hpi), the
culture supernatant containing the infected detached cells and
merosomes was collected and centrifuged at 160 g for 5 min. The
cells were then resuspended in 4% PFA/PBS and fixed for 20 min
at room temperature. Afterwards, cells were pelleted at 160 g for
5 min and resuspended in 50–100 ml of 4% PFA/PBS. The
solution was subsequently spread onto a microscope slide using a
cytospin centrifuge at 800 g for 4 min. The detached cells and
merosomes were incubated with 4% PFA/PBS for 15 min and
then with ice-cold methanol for 5 min. Cells were stained using
primary antibodies (chicken anti-ExpI, mouse or rat anti-MSP1,
and rat anti-PbICP-C or mouse anti-GFP, respectively), and,
subsequently, fluorescently labeled secondary antibodies (Cy5-
labeled antibody (Dianova) and Alexa594/488-labeled antibod-
ies (Molecular Probes)). DNA was visualized by staining with
10 mg/ml DAPI (Sigma). Stained cells were analyzed as
described above.
Transmigration assay
HepG2 cells were seeded at a density of 80,000 cells per well on
glass coverslips in 24-well plates. The next day, 10,000 sporozoites
of each parasite line were mixed with 1 mg/ml dextran-fluorescein
(10,000 MW, Molecular Probes) in PBS prior to co-incubation
with HepG2 cells. After a 1 h incubation (37uC, 5% CO2), cells
were washed three times in PBS, fixed with 4% PFA/PBS (20 min,
room temperature) and permeabilized with ice-cold methanol
(10 min). To visualize sporozoites, CSP-staining was performed
(rabbit anti-CSP, Alexa594-labeled anti-rabbit antibody, Molecu-
lar Probes). DNA was stained with 10 mg/ml DAPI (Sigma). The
number of transmigrated cells was determined by calculating the
percentage of dextran-fluorescein-positive cells compared to mock-
treated HepG2 cells.
Invasion assay
HepG2 cells were seeded at a density of 80,000 cells per well on
glass coverslips in 24-well plates. The day after seeding, cells were
infected with 10,000 sporozoites per well after or without pre-
incubation with 100 nM recombinant PbICP on ice for 30 min.
After culturing the infected cells for the times indicated, cells were
used for IFA and the number of infected HepG2 cells per coverslip
was determined. Antiserum directed against PbICP-C was used to
distinguish between ICPpos (SSR2 PbICPcond parasites, in which
site-specific recombination had not taken place) and pbicp-c knock
out PbICPcond parasites.
Assessment of parasite growth
To monitor parasite growth over the course of development,
parasite size was measured using the density slice module of the
OpenLab software version 5.0.4. [59]. Briefly, at different time
points after infection (30 hpi and 60 hpi), infected HepG2 cells
were fixed and stained using anti-P. berghei antisera (see above) to
visualize the parasite cytosol. Parasites were photographed using
an Axiovert 200 microscope (Zeiss) at620 magnification. Images
from each time point were merged and OpenLab software version
5.0.4 was used to calculate parasite area.
Counting infected, detached cells
To quantify the formation of infected, detached cells, HepG2
cells were seeded at a density of 40,000 cells per well on glass
coverslips in 24-well plates. The next day, wells with seeded cells
were infected with equal numbers of sporozoites, as described
above. To count non-fluorescent parasites, cells were infected in
duplicate; one set was fixed at 48 hpi to determine the number of
infected cells and the other set was used for assessment of detached
cell formation at 65 and 70 hpi. Infected cells per coverslip at
48 hpi were normalized as 100% of the parasite population for
each of three independent experiments. Corresponding cover slips
with infected cells were transferred to new wells in 24-well plates.
At 65 hpi, the culture supernatant containing the infected,
detached cells and merosomes of the infected cells was transferred
to a fresh well and pre-warmed media was added to the residual
infected cells. At 70 hpi, the culture supernatant containing the
residual infected, detached cells and merosomes was transferred to
a fresh well. To visualize host cell nuclei by live imaging, parasites
were stained with Hoechst 33342 (1 mg/ml, Molecular Probes). In
this assay, only infected, detached cells that contain a HepG2 cell
nucleus were counted using an Axiovert 200 microscope (Zeiss).
The ratio of mature detached cells was calculated in relation to the
number of infected cells 48 hpi.
Mouse infection
Female NMRI mice were each infected by intravenous (i.v.)
injection of 5,000 sporozoites of either the control UIS4/Flp(2),
PbICPcond, PbICPKO, or PbICPcomp strain or by transfer of 100 ml
blood by intraperitoneal (i.p.) injection from an infected mouse
with a parasitemia of 5%. Sporozoites were harvested from
infected mosquitoes at day 24–26 because before sporozoite
numbers in salivary gland of mosquitoes infected with the
PbICPKO strain were too small to be analysed. The onset of
blood stage infection was determined by blood smears beginning
one day post-infection.
Western blot
For analyzing expression of PbICP-C and MSP in blood stage
parasites by Western blot, saponin pellets of schizont stage
parasites were resuspended in 26 Laemmli buffer. For detection
of CSP and TRAP release in midgut and salivary gland
sporozoites, 2–56104 sporozoites of each parasite line were
directly placed in 16Laemmli buffer or incubated in Dulbecco’s
Modified Eagle Medium (DMEM), 2.5% fetal bovine serum,
50 mg/ml hypoxanthine and 25 mM HEPES for 35 min at 28uC.
The incubated samples were then centrifuged at 20,817 g for
4 min at 4uC and supernatant and pellet were harvested
separately. The supernatant was analyzed to quantify the release
of CSP and TRAP while the pellet was used as a loading control.
Proteins were separated on 8–12% SDS-PAGE gels under
reducing conditions and transferred to nitrocellulose membranes.
The membranes were incubated over night with antisera directed
Essential Protease Inhibitor for Plasmodium Parasite Development
PLOS Pathogens | www.plospathogens.org 15 August 2014 | Volume 10 | Issue 8 | e1004336
against PbICP-C (mouse antisera, 1:1000 dilution) [29], MSP1 (rat
antisera, 1:1000 dilution), or CSP (rabbit antisera, 1:1000
dilution). Alternatively, the membranes were incubated overnight
with mAb 3D11 (1 mg/ml) [60], anti-TRAP (1:300 dilution) [61],
or mAb 2E6 (1 mg/ml) [62]. Horseradish peroxidase-conjugated
secondary antibodies (Pierce) were subsequently applied for 1 h.
The signal was detected using the SuperSignal West Pico
Chemiluminescent Substrate (Pierce).
Metabolic labeling
Control and PbICPKO sporozoites were metabolically labeled in
DMEM lacking Cys/Met, containing 0.5% BSA and 400 mCi/ml
with L-[35S]Cys/Met, for 45 min at 28uC. After labeling,
sporozoites were washed and resuspended in incubation medium
and kept on ice or chased in DMEM with Cys/Met and 0.5%
BSA for 30 min at 28uC. Labeled sporozoites were pelleted after
incubation by centrifugation at 20,800 g for 4 minutes at 4uC.
The sporozoite pellets were lysed in 1% SDS, 4 M urea, 150 mM
NaCl, 50 mM Tris-HCl (pH 8.0), with protease inhibitor cocktail
for 1 hour at 4uC. Protein extracts were separated on an 8% SDS-
PAGE gel, as previously described [37]. The gel was fixed,
enhanced with Amplify (Amersham Pharmacia), dried, and placed
on film.
Quantification of oocyst and sporozoite numbers in
mosquitoes
A. stephensi mosquitoes were fed on mice infected with control
or transgenic parasites. On day 10 after the infective blood meal,
15–20 mosquito midguts were mounted on microscope slides and
oocysts were quantified using phase microscopy. On day 18 after
the infective blood meal, mosquito midguts, salivary glands, and
hemolymph were harvested for determination of sporozoite
numbers. For midgut and salivary gland sporozoites, 10 mosqui-
toes were dissected, organs pooled and homogenized, and released
sporozoites were collected and counted using a hemocytometer.
Hemolymph from 10 mosquitoes was collected by perfusion of the
thorax and abdomen with 5 ml of DMEM, and sporozoites were
counted using a hemocytometer.
Motility assay
Glass eight-chambered Lab-Tek wells (Nunc) were coated with
10 mg/ml mAb 3D11 in PBS overnight at 25uC and then washed
three times with PBS. Sporozoites were dissected in DMEM
containing 3% BSA. 56104 sporozoites per well were added to the
coated wells, incubated for 1 h at 37uC and fixed with 4% PFA.
To visualize CSP-containing trails, the wells were then incubated
with biotinylated mAb 3D11 followed by Streptavidin-FITC
(1:100 dilution, Amersham Pharmacia). Gliding motility was
quantified by counting the number of sporozoites associated with
trails and the number of circles.
Protease assays
MBP, MBP-PBICP and MBP-PbICP-GFP were recombinantly
expressed in E. coli bacteria and purified by affinity chromatog-
raphy on amylose resins. Papain (Sigma) was incubated with
30,8 mM Z-Phe-Arg-AMC substrate (Bachem) in the presence of
200 nM of the recombinant purified fusion proteins. Assay buffers
were 100 mM acetate buffer, 10 mM DTT, pH 5.5. Photometric
product formation (E) was measured every 10 seconds and activity
was calculated from the slope of the linear part of the graph (DE/
Dt). Protease activity in the presence of the control protein MBP
was set to 100% and residual activity in the presence of
recombinant fusion proteins was calculated.
Supporting Information
Figure S1 Conditional Gene Deletion of PbICP using the
UIS4/Flp System. (A) Schematic representations of the wild-
type pbicp locus and the pbicp recombinant loci in the UIS4/
FRT(2) clone (PbICPcontrol). The pPbICP/FRT plasmid contains
the 59end (0.6 kb) of the pbicp coding sequence (white box; PbI), a
FRT site (white arrow), the 39end of the pbicp coding sequence
(white box; CP), 0.6 kb of hdhfr 39 regulatory sequence (black
lollipop), a marker cassette (gray box), the plasmid backbone (thick
line), and the pbicp 39 regulatory sequence (0.6 kb, white lollipop).
The linearized plasmid integrated via double crossover (DCO)
recombination (as indicated by the dotted lines) at the pbicp locus
into UIS4/Flp(2) parasites (wt pbicp), generating the PbICPcond
clone. Arrows indicate the annealing sites of primers P1 (forward,
pbicp 59regulatory sequence), P2 (reverse, pbicp 39regulatory
sequence), P3 (reverse, pbicp downstream region), and P4 (forward,
hdhfr 39regulatory sequence) used for diagnostic PCR analysis.
SSR2 : before site-specific recombination; SSR+ : after site-
specific recombination. (B) Integration control at the pbicp locus in
PbICPcond parasites using primers P1–P4. To probe the pbicp
wild-type locus, PbICPcontrol parasites were included in this
analysis. PCR used genomic DNA of PbICPcontrol and uncloned
PbICPcond erythrocytic stages. The sizes of the DNA fragments
amplified from wild-type pbicp (wt), or integrated (int.) loci are
shown. (C) Excision efficiency at the pbicp locus in PbICPcond
parasites was assessed by PCR of parasite genomic DNA using
primers P1 and P3 and PbICPcond parasites before (preclon) and
after cloning (cloned PbICPcond). PbICPcond parasites were either
collected from blood of a infected mouse prior to mosquito passage
(BS), from midgut of infected mosquitoes (MG) collected 11 days
after infection, or from salivary gland (SG) collected day 19 after
infection and used for PCR. The sizes of the DNA fragments
amplified from pbicp excised (SSR+) or non-excised (SSR2) loci
are shown. As a control, primers specific for pbicp were used
(bottom panel).
(TIF)
Figure S2 Integration analysis of PbICPcontrol-GFP and
PbICPcomp parasites via PCR. (A) Schematic representation
of the pL0017-PbICP-GFP/GFP constructs. The plasmids contain
the d-ssurrna cassette (light gray box), marker cassette (dark gray
box), pbeef1aa promotor region, pbicp-gfp/gfp coding sequences
(open box PbICP-GFP/GFP), and 0.5 kb of the ts/dhfr 39regu-
latory sequence (black lollipop). The linearized plasmids (linear-
ized within the d-ssurrna cassette) can integrate via single crossover
recombination at the d-ssu-rrna and c-ssu-rrna locus because both
loci are highly homologous. Plasmids were either transfected into
PbICPcontrol or PbICPKO parasites, generating the PbICPcontrol-
GFP or PbICPcomp clone. Arrows indicate the annealing sites of
forward primers P1 that specifically detects the d-ssu-rrna
sequence or P2 that specifically detects the c-ssu-rrna sequence,
P3 (reverse, pbeef1aa regulatory sequence) and P4 (reverse, d-ssu-
rrna and c-ssu-rrna sequence) used for diagnostic PCR analysis.
(B) Integration efficiency at the ssu-rrna-loci in PbICPcontrol-GFP
and PbICPcomp parasites using primers P1–P4 on genomic DNA
of PbICPcontrol-GFP (GFP) and PbICPcomp (comp) erythrocytic
stages. To probe the pbicp locus, primers specific for pbicp were
used. The sizes of the DNA fragments amplified from wild-type
ssu-rrna (wt), integrated (inte), or pbicp loci are shown. (C)
Recombinant PbICP-GFP inhibits papain activity. Recombinant
PbICP-GFP was produced in E. coli as a maltose binding protein
(MBP)-tagged soluble protein and purified from the bacterial lysate
by amylose-bead affinity chromatography. Hydrolysis of the Z-
Phe-Arg-AMC substrate by papain was measured in the presence
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of MBP, MBP-PbICP, or MBP-PbICP-GFP (all 200 nM).
Protease activity in presence of 200 nM MBP was considered
100% and the percentage of residual protease activity was
calculated relative to this activity. (D) Statistical evaluation of the
experiment presented in Figure 1C. Briefly, mice were infected by
i.p. injection of 100 ml of blood from infected mice with a
parasitemia of 5% (adjusted using PBS). The onset and
development of a blood stage infection was determined by
observation of blood smears. Development of parasitemia at day
3 post-infection was compared by Student’s t test (* = P,0.05; ns,
not significant).
(TIF)
Figure S3 PbICP is not essential for parasite develop-
ment in the mosquito midgut but is important for
sporozoite motility and transmigration to HepG2 cells.
(A) Oocyst numbers in infected mosquitoes. Mosquitoes (15–20
per treatment group) infected with PbICPcontrol or PbICPKO
parasites, were dissected 10 days after blood feeding, and the
number of oocysts per midgut was determined. The number of
oocysts per mosquito and the mean of all data per parasite strain
from two independent trials are shown. Differences between
PbICPcontrol and PbICPKO parasites were compared using
Student’s t test (ns, not significant). (B) Quantification of sporozoite
numbers in the mosquito midgut. Mosquitoes infected with
PbICPcontrol, PbICPKO, or PbICPcomp parasites were dissected
10 days after a blood meal and the number of sporozoites
associated with the midgut was determined. Results are the
means 6 S.D. of two independent trials. Differences between
PbICPcontrol, PbICPKO, and PbICPcomp parasites were compared
using Student’s t test (ns, not significant). (C) Analysis of motility
in salivary gland sporozoites. Salivary glands infected with
PbICPcontrol or PbICPKO parasites were dissected and sporozoites
were incubated on glass slides coated with mAb 3D11. After
staining with antiserum specific for CSP, the number of
sporozoites associated with CSP trails was counted and the
number of circular trails per sporozoite was quantified. The mean
(6 S.D.) number of sporozoites producing 0, 1–10, or .10
circular trails in two independent trials is shown. Differences
between PbICPcontrol and PbICPKO parasites were compared
using Student’s t test (* = P,0.05 and *** = P,0.0005). (D) Pulse-
chase metabolic labeling of midgut or salivary gland sporozoites.
Mosquitoes were infected with PbICPcontrol (control) or PbICPKO
(KO) parasites by blood feeding on an infected mouse. Midgut
(MG) and salivary gland (SG) sporozoites were metabolically
labeled for 45 min and either placed on ice (time = 0) or chased
with unlabeled amino acids for 30 min (time = 30). Sporozoites were
then centrifuged, lysed and analyzed by SDS-PAGE and autoradi-
ography. (E) Quantification of transmigrated HepG2 cells incubated
with 16104 control (PbICPcontrol) or PbICPKO parasites, or cells not
exposed to parasites (mock), in the presence of fluorescein dextran. At
1 hpi, HepG2 cells were fixed and dextran-positive cells were
quantified. The relative transmigration rate (rel. trans. rate) of
PbICPKO parasites in relation to control parasites (set to 100%) is
shown. Results are the means 6 S.D. from two independent
measurements. Differences between control and PbICPKO parasites
were compared using Student’s t test (**** = P,0.0001).
(TIF)
Figure S4 PbICP is essential for sporozoite invasion and
cannot be substituted by external recombinant PbICP.
(A) Infected HepG2 cells incubated with either 16104 PbICPcontrol
(UIS4/Flp(2)), PbICPcond, or PbICPKO parasites were quantified
at 5 hpi. PbICP-C-positive parasites (striped bars) are indicated.
EEFs were quantified by IFA as shown in Figure 4. Differences
between PbICPcontrol and pbicp-transgenic parasites (PbICPcond,
PbICPKO) were compared using Student’s t test (* = P,0.05) and
standard deviations (S.D.) are indicated. (B) IFA of HepG2 cells
infected with either PbICPcontrol (upper panel) or PbICPcond (lower
panel) parasites and fixed 5 hpi. Cells were stained with rabbit
anti-UIS4 antiserum (green) and rat anti-PbICP-C antiserum
(red). Secondary antibodies were anti-rabbit Alexa488 and anti-rat
Alexa594. DNA was stained with DAPI (blue). Scale bars: 5 mm.
Representative pictures are shown. Note that at 5 hpi all
PbICPcond parasites analyzed have still been PbICP positive. (C)
Externally added recombinant PbICP does not rescue sporozoite
infectivity. Infected HepG2 cells incubated with either 16104
PbICPcontrol (control+ICP) or PbICPKO (KO+ICP) salivary gland
sporozoites that had been pre-incubated with 100 nM recombi-
nant PbICP on ice for 30 min. Infected cells were quantified by
IFA as shown in Figure 4. Results are the means 6 standard
deviation (S.D.). Differences between PbICPcontrol and PbICPKO
were compared using Student’s t test (**** = P,0.0001).
(TIF)
Figure S5 PbICP is important for late liver stage
development. (A) IFA of HepG2 cells infected with either
PbICPcontrol (upper panels) or PbICPcond (lower panels) parasites,
fixed at 55 hpi (cytomere stage) or 60 hpi (merozoite stage). Cells
were stained with mouse anti-MSP1 (green), rat anti-PbICP-C
(red), and chicken anti-Expl (cyan). Secondary antibodies were:
anti-mouse Alexa488, anti-rat Alexa594 and anti-chicken Cy5.
DNA was stained with DAPI (blue). Scale bars: 10 mm. White
arrow: vacuole surrounded by a MSP1-positive membrane. (B)
Restricted liver stage development of PbICPcond parasites. Infected
HepG2 cells incubated with either 16104 PbICPcontrol or
PbICPcond were quantified at 60 hpi. Differentiation of PbICP-
C-positive (striped bars) or PbICP-C-negative (black bars) EEFs
was quantified by IFA as described in Figure 4. PbICPKO parasites
have not been included in this analysis because as shown earlier,
they do not infect HepG2 cells at all. Results are the means 6
standard deviation (S.D.) from three independent trials. Also
shown is the relative infection rate (rel. inf. rate) of PbICPcond
parasites in relation to PbICPcontrol parasites. Differences between
PbICPcontrol and PbICPcond were compared using Student’s t test
(**** = P,0.0001). (C) Cell detachment assay at 70 hpi confirms
that detachment of PbICPcond infected cells is strongly reduced
and not only delayed. Quantification of PbICPcontrol and
PbICPcond infected cells detached between 65 hpi and 70 hpi is
shown. HepG2 cells were infected with either PbICPcontrol or
PbICPcond sporozoites and infected cells were quantified 48 hpi
(value normalized to 100%). At 65 hpi, detached cells in the
supernatant were removed and counted (Figure 5B) and pre-
warmed media was added to the cultures. At 70 hpi, the
supernatant was again removed and stained with Hoechst
33342. The number of infected, detached cells was quantified
and the ratio between infected cells 48 hpi and cells detached
between 65 hpi and 70 hpi was calculated. Results are the means
6 standard deviation (S.D.). Differences between PbICPcontrol and
PbICPcond were compared using Student’s t test (** = P,0.001).
(TIF)
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